C Avancès1, W Jacot, P Sénesse, S Culine. Show Affiliations » 1. Department of Medical Oncology, CRLC Val d'Aurelle, Montpellier, France.
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseAdenocarcinoma/bloodAdenocarcinoma/drug therapyAdenocarcinoma/secondaryAgedAntineoplastic Combined Chemotherapy Protocols/therapeutic useBone Neoplasms/bloodBone Neoplasms/drug therapyBone Neoplasms/secondaryCisplatin/administration & dosageDisseminated Intravascular Coagulation/bloodDisseminated Intravascular Coagulation/drug therapyDocetaxelHumansMalePaclitaxel/administration & dosagePaclitaxel/analogs & derivativesPlatelet CountProstatic Neoplasms/bloodProstatic Neoplasms/drug therapyTaxoidsTreatment Outcome
Substances: See more » TaxoidsDocetaxelPaclitaxelCisplatin
Year: 2002 PMID: 12352431 DOI: 10.1097/01.ju.0000030190.90157.da
Source DB: PubMed Journal: J Urol ISSN: 0022-5347 Impact factor: 7.450